(19)
(11) EP 4 577 186 A1

(12)

(43) Date of publication:
02.07.2025 Bulletin 2025/27

(21) Application number: 23761124.9

(22) Date of filing: 24.08.2023
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 38/48(2006.01)
A61L 15/42(2006.01)
A61K 9/70(2006.01)
A61P 7/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0014; A61K 9/7007; A61K 9/7023; A61K 38/4846; A61P 7/04; A61L 15/425; A61L 15/44; A61L 15/28; A61L 2300/418; C12Y 304/21021
 
C-Sets:
A61L 15/28, C08L 3/02;
(86) International application number:
PCT/EP2023/073194
(87) International publication number:
WO 2024/042148 (29.02.2024 Gazette 2024/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 26.08.2022 EP 22192409
15.06.2023 US 202318210190

(71) Applicant: Stellaris Pharmaceuticals ApS
1619 Copenhagen (DK)

(72) Inventor:
  • SCHJOLDAGER, Birgit Ter-Borch Gram Lilienfeldt
    1619 Copenhagen (DK)

(74) Representative: IPTector Consulting ApS 
Diplomvej 377
2800 Kgs. Lyngby
2800 Kgs. Lyngby (DK)

   


(54) HAEMORRHAGE INHIBITING COMPOSITIONS AND METHODS INVOLVING THE SAME